首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Journal of experimental therapeutics and oncology

缩写:

ISSN:1359-4117

e-ISSN:1533-869X

IF/分区:0.0/N/A

文章目录 更多期刊信息

共收录本刊相关文章索引497
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Xiaohua Gao,Dorrah Deeb,Hao Jiang et al. Xiaohua Gao et al.
Malignant glioma cells are generally resistant or only weakly sensitive to tumor necrosis factor family of cell death-inducing ligands, including TNF-related apoptosis-inducing ligand (TRAIL)/Apo2L. The chemopreventive activity of polypheno...
Carla Mendes Maciel,Magno Junqueira,Marcos Eduardo Machado Paschoal et al. Carla Mendes Maciel et al.
Based on the assumption that proteins can emanate from tumour to serum, we investigated whether serum low molecular weight proteins (LMW) can discriminate lung cancer patients from healthy donors. Pooled sera from 20 lung cancer patients ma...
Tadeusz Sebzda,Yousif Saleh,Maria Malicka-Blaszkiewicz et al. Tadeusz Sebzda et al.
Aim: Actin microfilaments are components of cytoskeleton, the structure involved in many cellular functions, including cell motility, and morphology, its necessary for tumor progression and metastasis. We investigated the...
Suva Samanta,Anindita Pain,Sushanta Dutta et al. Suva Samanta et al.
Nitronaphthal-NU (Compound 1) was synthesized as a mixed-function antitumor agent based on the structures of the clinical drug CCNU and experimental compound Mitonafide. In vitro screening in four human tumor cell lines namely SNB-78 CNS, H...
Hans-Joachim Ochel Hans-Joachim Ochel
Radiobiological experiments routinely require the estimation of cellular survival. Several cytotoxicity assays have been proposed, which have inherent advantages and disadvantages. The performance of one of them, the crystal violet dissolut...
Giovanni Angelini,Domenico Bonamonte,Mong-Shang Lin et al. Giovanni Angelini et al.
Our labs are pursueing the goal of exactly defining the qualities of peptide antigenicity, immunogenicity and pathogenicity in order to develop safe specific immunotherapies by utilizing specific portions of disease-associated-proteins (DAP...
Fumihiro Oshita,Kouzo Yamada,Haruhiro Saito et al. Fumihiro Oshita et al.
We conducted a phase II study of combination chemotherapy with nedaplatin (NP) with irinotecan (CPT) to determine the effects against unresectable non-small cell lung cancer (NSCLC) and to determine the qualitative and quantitative toxiciti...
Bo Han,Gengyin Zhou,Qinghui Zhang et al. Bo Han et al.
Arsenic trioxide (ATO) has been established to be an effective agent for treating newly diagnosed and relapsed acute promyelocytic leukemia (APL) patients. Laboratory data suggest that ATO induces apoptosis of hematopoietic or several solid...
Carla Mendes Maciel,Marcos Eduardo Machado Paschoal,Márcia Tie Kawamura et al. Carla Mendes Maciel et al.
Lung cancer is one of the leading causes of cancer deaths worldwide. The poor patients prognosis is largely attributable to the lack of effective early detection methods. Based on the concept that proteins and peptides can emanate from tumo...
Faye M Johnson,Peiying Yang,Robert A Newman et al. Faye M Johnson et al.
Imatinib mesylate is a novel anti-tumor agent useful in the clinical management of chronic myelogenous leukemia and gastrointestinal stromal tumors with minimal toxicity relative to other forms of cancer therapy. Its clinical activity and m...